L
Lyell Immunopharma D
D
LYEL
0.70000
USD
0.04
(5.88%)
مغلق
حجم التداول
19,122
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
204,513,159
المقالات
العنوان: Lyell Immunopharma
القطاع: Healthcare
الصناعة: Biotechnology
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.